EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulation of the PI3K/Akt signaling pathway by steroidal saponins: therapeutic implications in cancer

Mohammad Bagher Majnooni, Maryam Naseri, Shayan Bakhshy-Chenary, Younes Zeinalii, Mahdis Azadi, Mohammad Hosein Farzaei, Sajad Fakhri, Syed Mustafa Ghanadian, Javier Echeverría

Frontiers in Pharmacology · 29.04.2026 · 17

DOI: 10.3389/fphar.2026.1779073 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.04.2026. Verfasst von Mohammad Bagher Majnooni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. Die Arbeit nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway is considered essential for cancer progression and the regulation of cellular processes, including proliferation, survival, metastasis, and angiogenesis. Conventional therapies using targeted agents such as alpelisib and everolimus have limited the effectiveness of inhibitors in exploiting effective resistance mechanisms. Steroidal saponins (SSs) are a diverse group of natural compounds recognized as anticancer agents that target multiple cells and pathways.

Purpose

To synthesize current evidence on how SSs modulate the PI3K/Akt pathway to produce anticancer effects and to outline translational opportunities and limitations.

Methods

We conducted a review of preclinical and translational studies indexed in PubMed/Scopus/Google Scholar up to August 2025. Studies were included if they reported mechanistic or functional modulation of the PI3K/Akt/mTOR axis ( in vitro , in vivo , or ex vivo ). Relevant data were compiled and organized based on compound class, experimental model, dose/exposure, and PI3K/Akt-related molecular readouts. Results and Discussion This review highlights the potential of SSs to target the PI3K/Akt pathway and combat cancer progression, and addresses the limitations of conventional therapies in overcoming therapeutic resistance. SSs, as small-molecule phytochemicals, exert anticancer effects through the induction of apoptosis, inhibition of metastasis and angiogenesis, alteration of the tumor microenvironment to therapeutic advantage, promotion of the immune response, and other mechanisms that reverse multidrug resistance by modulating the PI3K/Akt pathway.

Conclusion

The combination of SSs with chemotherapeutic agents, given emerging preclinical evidence of small-molecule efficacy, supports the development of new anticancer therapies. However, the development of SSs for clinical use remains limited due to their low bioavailability, systemic toxicity, and lack of target specificity.

Schlagwörter

Stichwörter der Autor:innen

PI3K/AKT signalingangiogenesis inhibitionanticancer activityapoptosismultidrug resistancesteroidal saponins

Autor:innen und Institutionen

  • Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Pharmacognosy, Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Departamento de Ciencias del Ambiente, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.

Zitieren

APA

Majnooni, M. B., Naseri, M., Bakhshy-Chenary, S., Zeinalii, Y., Azadi, M., Farzaei, M. H., Fakhri, S., Ghanadian, S. M., & Echeverría, J. (2026). Modulation of the PI3K/Akt signaling pathway by steroidal saponins: therapeutic implications in cancer. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1779073

Vancouver

Majnooni MB, Naseri M, Bakhshy-Chenary S, Zeinalii Y, Azadi M, Farzaei MH, et al. Modulation of the PI3K/Akt signaling pathway by steroidal saponins: therapeutic implications in cancer. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1779073

BibTeX
@article{Majnooni2026,
  author = {Majnooni, Mohammad Bagher and Naseri, Maryam and Bakhshy-Chenary, Shayan and Zeinalii, Younes and Azadi, Mahdis and Farzaei, Mohammad Hosein and Fakhri, Sajad and Ghanadian, Syed Mustafa and Echeverría, Javier},
  title = {Modulation of the PI3K/Akt signaling pathway by steroidal saponins: therapeutic implications in cancer},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1779073}
}
Kostenlos starten →